Icon Legend

This session is not in your agenda.

This session is in your agenda. Click to remove it

Browse by Author

Home
Browse by Author

Browse by Author

Type here to filter the list

L
Layton, Benjamin

Mayo Clinic

P-054 - (Poster #54) Stiff Person Syndrome in the Hospice Setting: A Case Report of Collaborative Symptom Management
Location: Exhibit Hall (Level 4)

Benjamin Layton

Favorite

Lederman, Seth

Tonix Pharmaceuticals, Inc.

P-036 - (Poster #36) Sublingual cyclobenzaprine (TNX-102 SL) for fibromyalgia: efficacy and safety in two randomized placebo-controlled trials
Location: Exhibit Hall (Level 4)

Seth Lederman

Favorite

P-037 - (Poster #37) TNX-102 SL, cyclobenzaprine HCl sublingual tablets, demonstrates pain reduction and favorable tolerability in patients with fibromyalgia
Location: Exhibit Hall (Level 4)

Seth Lederman

Favorite

P-045 - (Poster #45) Steady-state pharmacokinetic properties of a sublingual formulation of cyclobenzaprine (CBP) HCl (TNX-102 SL): comparison to simulations of oral immediate-release CBP
Location: Exhibit Hall (Level 4)

Seth Lederman

Favorite

P-046 - (Poster #46) Randomized, double-blind, placebo-controlled confirmatory Phase 3 trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in fibromyalgia
Location: Exhibit Hall (Level 4)

Seth Lederman

Favorite

Lee, Seunghoon

Department of Acupuncture and Moxibustion Medicine, Kyung Hee University Medical Center

P-072 - (Poster #72) Clinical Outcomes and Associated Factors of Korean Medicine Inpatient Care for Acute Neck and Low Back Pain Following Traffic Accidents : A Retrospective Chart Review
Location: Exhibit Hall (Level 4)

Seunghoon Lee

Favorite

P-075 - (Poster #75) The opioid-sparing effect of acupuncture after abdominal surgery: a systematic review and meta-Analysis of randomized controlled trials
Location: Exhibit Hall (Level 4)

Seunghoon Lee

Favorite

Lemieux, Rachel

n/a

P-025 - (Poster #25) Improving Patient Acquisition Through Digital Visibility: A Two-Clinic Case Study on Website Optimization, Local Listings, and Social Media Engagement
Location: Exhibit Hall (Level 4)

Rachel Lemieux

Favorite

Lemus, Anthony

REV Pharmaceuticals

P-033 - (Poster #33) REVFLEX™, A Superior Muscle Recovery Technology supported by Non-Clinical and Clinical Use Studies
Location: Exhibit Hall (Level 4)

Anthony Lemus

Favorite

Lesnick, Marc

Tris Pharma, Inc.

P-044 - (Poster #44) Results of a Randomized, Placebo-Controlled, Phase 3 Trial of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
Location: Exhibit Hall (Level 4)

Marc Lesnick

Favorite

LIM, JUNGHYUN

Kyung Hee University Korean Medicine Hospital

P-068 - (Poster #68) Bibliometric Analysis of Randomized Controlled Trials for Lumbar Herniated Intervertebral Discs: 1990–2024
Location: Exhibit Hall (Level 4)

JUNGHYUN LIM

Favorite

Lin, Kyaw

Touro

P-055 - (Poster #55) Skeletal Dysplasia and Carpal Tunnel Syndrome: A Case Report
Location: Exhibit Hall (Level 4)

Kyaw Lin

Favorite

Liptan, Ginevra

Fibromyalgia Research Library and The Fibro Show

CPM-01 - Clearing the Fog: What the Science Actually Shows About the Pathophysiology of Fibromyalgia
Location: Castellana 1 (Level 3)

Ginevra Liptan

Favorite

CPM-02 - Fibro: Getting Better is Possible! An MD and Health Coach Get Personal on Treating Fibromyalgia
Location: Nolita (Level 4)

Ginevra Liptan

Favorite

Li, Sean

National Spine and Pain Centers

INTV-01 - Electrifying the Nervous System: Selecting Appropriate Patients for Neuromodulation Therapies
Location: Nolita (Level 4)

Sean Li

Favorite

INTV-03 - Measure Twice and Cut Once: Preventing and Mitigating Complications in Neuromodulation Therapy
Location: Mont Royal (Level 4)

Sean Li

Favorite

Li, Shuai

Shanghai SIMR Biotechnology Co., Ltd.

P-071 - (Poster #71) Quantitative Sensory Testing of SR419, a First-in-Class Oral α5-GABAA Receptor Negative Allosteric Modulator, in Neuropathic Pain Patients
Location: Exhibit Hall (Level 4)

Shuai Li

Favorite

Liu, Mark

Viatris

P-041 - (Poster #41) Pharmacokinetics study comparing MR-107A-02 (novel fast-acting meloxicam formulation) 15mg tablet with meloxicam (Mobic®) 15mg in healthy adult male subjects
Location: Exhibit Hall (Level 4)

Mark Liu

Favorite

Loeb, Aletha

UC Davis Health

P-024 - (Poster #24) Evaluation of Flexible Buprenorphine Dosing in Patients with Chronic Pain
Location: Exhibit Hall (Level 4)

Aletha Loeb

Favorite

Lojeski, Edwin

Kaiser Permanente Washington

P-107 - (Poster #107) EVALUATING OUTCOMES OF TRANSITIONING FROM FULL OPIOID AGONIST USE TO BUPRENORPHINE
Location: Exhibit Hall (Level 4)

Edwin Lojeski

Favorite

Lubarda, Jovana

Medscape LLC

P-008 - (Poster #8) National Trends in Acute Pain Management: Preliminary Insights from a 2025 Pain Management Survey
Location: Exhibit Hall (Level 4)

Jovana Lubarda

Favorited

Luciani, Lisa

Altoona VAMC

P-014 - (Poster #14) Effect of Long-Term Opioid Therapy on Sexual Dysfunction in Pain Patients
Location: Exhibit Hall (Level 4)

Lisa Luciani

Favorite

Luciani, Lisa

James E. Van Zandt Veterans Affairs Medical Center

P-034 - (Poster #34) An Exploration of Painful Neuropathy in the Context of Long Covid: Mechanisms, Manifestations, and Management
Location: Exhibit Hall (Level 4)

Lisa Luciani

Favorite